GJE_llp Profile Banner
Gill Jennings & Every Profile
Gill Jennings & Every

@GJE_llp

Followers
509
Following
123
Media
461
Statuses
1K

We're a leading European Intellectual Property firm based in London. We can help you turn your innovations, brands and designs into commercial success.

London, England
Joined May 2014
Don't wanna be here? Send us removal request.
@GJE_llp
Gill Jennings & Every
3 years
The Unified Patent Court (#UPC) and Unitary Patent (#UP) era has begun. GJE's expert patent attorneys are here to guide you through these new options for protecting your #inventions. Find out more here: https://t.co/qacp0p38g4 #IP #intellectualproperty
0
0
1
@GJE_llp
Gill Jennings & Every
2 years
Season's Greetings from all of us at GJE! 🎄 We wish you a merry & bright festive season & hope you are looking forward to the Christmas holidays. We asked our team of festive fashionistas to show off their #Christmas jumpers & they didn't disappoint!
0
0
0
@GJE_llp
Gill Jennings & Every
2 years
Breaking down a landmark High Court decision, Peter Arrowsmith analyses the expanded scope for #patenting #MachineLearning in the UK. He explores the challenges to established practices and the new possibilities that lie ahead. https://t.co/ki6P20wjSY #IP
0
0
0
@GJE_llp
Gill Jennings & Every
2 years
Exploring the intersection of #patents, medical #innovation, and technology evolution, Dom Jaques delves into the dynamic landscape since the 1973 EPC. Are current provisions in harmony with the transformative power of #AI and surgical robotics? https://t.co/ikoA7uIIbd #MedTech
0
0
0
@GIANT_health
GIANT Health Event
2 years
📣👉Join @GJE_llp Senior Associate and European and UK Patent Attorney, Jack Severs at the Future Hospital Show #GIANT2023 for his talk “Unlocking the value of Innovation: The IP Roadmap for HealthTech #startups”. #Digitalhealth #healthcare #healthtech #innovation #event
0
3
2
@GIANT_health
GIANT Health Event
2 years
0
4
4
@GIANT_health
GIANT Health Event
2 years
Join Dominic Jaques, European and UK Patent Attorney @GJE_llp for his talk “IP for Digital Therapeutics: Opportunities and Challenges” at #GIANT2023 on 5 Dec, London. In this talk, Dominic will explore the importance of #IP in the #digitalhealth sector. 🎫 https://t.co/1sK9lPotdu
0
3
3
@GIANT_health
GIANT Health Event
2 years
Join @GJE_llp Senior Associate and European and UK Patent Attorney, Jack Severs on 4 Dec,London at #GIANT2023 for his talk “Unlocking the value of Innovation: The #IP Roadmap for #HealthTech #startups” Register now: https://t.co/1sK9lPotdu #innovation #healthcare #digitalhealth
0
4
4
@GIANT_health
GIANT Health Event
2 years
GIANT Health announces our sponsor & exhibitor @GJE_llp at #GIANT2023 on 4-5 Dec. Gill Jennings & Every LLP is a leading firm of European Patent and Trade Mark Attorneys. Register now and join UK's leading community of #healthcare innovators: 🎫 https://t.co/1sK9lPp132 #healthtech
0
3
2
@GJE_llp
Gill Jennings & Every
2 years
UK MHRA approved CASGEVY™, the world's first #CRISPR-based gene therapy for Sickle Cell Disease & beta thalassemia on 16 Nov 2023. CASGEVY™ brings hope to patients with life-altering diseases. Ross Cummings & Kessia Hawkins report: https://t.co/hzBA6u8v9V #IP #GeneTherapy
0
0
0
@GJE_llp
Gill Jennings & Every
2 years
Milestone #mRNA vaccine success fuels a resurgence in RNA therapy. Jake Rightmyer delves into the 4 key categories of RNA drugs, emphasising the transformative influence of #Nobel laureates like Profs. Kariko and Weissman. Read more here: https://t.co/3Qm4qhgrYb
0
0
0
@GJE_llp
Gill Jennings & Every
2 years
Alice Anderson & Kayleigh Su regularly review changes to #trademark law & practice at the UKIPO, EUIPO & in other jurisdictions so that we can keep abreast of the latest developments. Read more here: https://t.co/uKbObezx7t
0
0
0
@GJE_llp
Gill Jennings & Every
2 years
The EPO have published the eagerly anticipated G1/22 and G2/22 decision, providing guidance on the assessment of priority claims at the #EPO. Rebecca Matheson and Alex Kelly report the key findings of this important decision. https://t.co/0m9ucV6nzd #iplaw #patent
0
0
1
@GJE_llp
Gill Jennings & Every
2 years
The #Legal500 has ranked Edward Carstairs as a Next Generation Partner for 2024! 🎉Congratulations to Edward on this fantastic achievement. https://t.co/RN3uTzF8Zm
0
0
0
@GJE_llp
Gill Jennings & Every
2 years
We’d like to congratulate Rebecca Matheson, Senior Associate in our Chemistry and Life Sciences team, who has been ranked as a Rising Star in the 2024 edition of the #Legal500! ⭐
0
0
0
@GJE_llp
Gill Jennings & Every
2 years
We are very pleased to be recognised in the 2024 edition of @thelegal500. This year saw more GJE attorneys individually recognised by the publication than ever before. Congratulations to all those ranked. 🎉 https://t.co/RN3uTzF8Zm #Legal500
0
0
0
@GJE_llp
Gill Jennings & Every
2 years
🔍 Our experts (Philippa, Stanley, Dominic, & James) stay updated on global patent law changes from #UKIPO, #EPO & more. Reach out to your GJE contact for insights on their impact. https://t.co/7q1ihUlRjo #PatentLawUpdates #IP
0
0
0
@GJE_llp
Gill Jennings & Every
2 years
We would like to congratulate Peter Arrowsmith on his ranking in IAM Strategy 300: The World’s Leading #IP Strategists 2023! 👏Read more here: https://t.co/ZzoAzMnjnH #IAM300 #Intellectualproperty
0
0
0
@GJE_llp
Gill Jennings & Every
2 years
Securing #patent protection for #DigitalTherapeutics (DTx) inventions in Europe offers great opportunities. Jack Severs explores the #EPO's approach to assessing #DTx innovations, highlighting the intricacies of patentability in this emerging field. https://t.co/zYgyninyH1
0
0
0
@GJE_llp
Gill Jennings & Every
2 years
In our latest #legal update Ash Earl and Tom Blackburn analyse the recent decision in T 873/21, exploring how the Enlarged Board of Appeal's guidance in G 2/21 is being applied at the #EPO Read more here: https://t.co/n9QtyjTegi
0
0
0
@GJE_llp
Gill Jennings & Every
2 years
Samantha Wallworth's latest article highlights the crucial link between #IP and #venturecapital success, emphasising the need for tailored strategies by #patent attorneys to reduce risk and boost rewards. Read more here: https://t.co/ScxBzmSK3Q
0
0
1